Immunogenicity and Safety of a Newly Developed Tetanus-Diphtheria Toxoid (Td) in Healthy Korean Adolescents: a Multi-center, Randomized, Double-blind, Active-Controlled Phase 3 Trial-Reference-Cited by-同舟云学术

Immunogenicity and Safety of a Newly Developed Tetanus-Diphtheria Toxoid (Td) in Healthy Korean Adolescents: a Multi-center, Randomized, Double-blind, Active-Controlled Phase 3 Trial

Published:2021 Issue:49 Volume:36 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Choi Ui Yoon¹^ORCID,Kim Ki Hwan²^ORCID,Lee Jin³^ORCID,Eun Byung Wook⁴^ORCID,Kim Hwang Min⁵^ORCID,Lee Kyung-Yil⁶^ORCID,Kim Dong Ho⁷^ORCID,Ma Sang Hyuk⁸^ORCID,Lee Jina⁹^ORCID,Kim Jong-Hyun¹⁰^ORCID

Affiliation:

1. Department of Pediatrics, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

2. Department of Pediatrics, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

3. Department of Pediatrics, Hanil General Hospital, Seoul, Korea.

4. Department of Pediatrics, Nowon Eulji University Hospital, Eulji University School of Medicine, Seoul, Korea.

5. Department of Pediatrics, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.

6. Department of Pediatrics, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

7. Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea.

8. Department of Pediatrics, Changwon Fatima Hospital, Changwon, Korea.

9. Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

10. Department of Pediatrics, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Funder

Boryung Biopharma Co., Ltd

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2021.36.e313